...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Notice of Meeting and Information Circular on SEDAR

The Notice of Meeting and the Management Information Circular for the upcoming Zenith September 12th AGM are now posted on SEDAR. 

BearDownAZ 

Share
New Message
Please login to post a reply